You are here

asthma

Fasenra shows benefit in acute asthma and COPD in Phase II trial

Clinical Trials Arena

Sun, 12/1/24 - 11:48 am

clinical trials

FDA finds widely used asthma drug impacts the brain, Reuters reports

CNBC

Fri, 11/22/24 - 11:11 am

AstraZeneca heads to regulators after Airsupra asthma trial stops early thanks to 'overwhelming efficacy'

Fierce Pharma

Mon, 10/7/24 - 09:50 pm

GSK's long-acting asthma drug halved attacks in phase 3, backing up blockbuster hopes

Fierce Biotech

Mon, 09/9/24 - 11:14 am

clinical trials

Sanofi reports positive data from Phase II asthma treatment trial

Clinical Trials Arena

Thu, 05/23/24 - 10:58 am

clinical trials

Blackstone unearths Uniquity Bio with $300M to explore Merck drug's I&I potential

Fierce Biotech

Wed, 05/15/24 - 11:21 am

Blackstone Life Sciences

Senator Maggie Hassan Blasts GSK for Discontinuing Common Children’s Asthma Inhaler to Dodge Price Cap

Xtalks

Tue, 05/7/24 - 06:29 pm

GSK joins AstraZeneca, Boehringer in capping US out-of-pocket inhaler prices at $35 per month

Fierce Pharma

Thu, 03/21/24 - 06:37 pm

Boehringer Ingelheim

RAPT Therapeutics Shares Plunge Premarket on FDA Study Hold

Morningstar

Tue, 02/20/24 - 11:17 am

RAPT Therapeutics

clinical trials

atopic dermatits

Discontinued GSK asthma drug stirs frustrations

Beckers Hospital Review

Wed, 02/14/24 - 06:36 pm

GSK Puts $1.4B on the Line in Aiolos Acquisition to Boost Asthma Pipeline

BioSpace

Tue, 01/9/24 - 09:50 am

Connect Biopharma plots phase 3 regulatory path after asthma asset hits mid-stage trial goals

Fierce Biotech

Tue, 12/12/23 - 11:21 am

Connect Biopharma

clinical trials

Aiolos Bio launches with ex-Gyroscope CEO at the helm, nearly $250M to advance severe asthma med

Fierce Biotech

Tue, 10/24/23 - 09:48 am

Apogee Files for IPO with Promising Preclinical Immuno Asset

BioSpace

Sun, 06/25/23 - 09:37 pm

Paragon Therapeutics

atopic dermatitis

Pieris stock deflates as AstraZeneca stops trials of asthma drug in response to toxicology signal

Fierce Biotech

Wed, 06/21/23 - 10:54 am

clinical trials

AstraZeneca, Amgen's asthma launch Tezspire picks up backing from England's NICE

Fierce Pharma

Wed, 03/29/23 - 09:58 am

Dupixent kicks off 2023 as top pharma brand for ad impressions

Medical Devices and Diagnostics Industry

Mon, 02/6/23 - 06:13 pm

pharma advertising

AstraZeneca and Avillion win approval for new asthma rescue treatment in adults

Endpoints

Wed, 01/11/23 - 10:53 am

Could AstraZeneca's Asthma Drug Candidate Generate Billions?

Motley Fool

Tue, 12/20/22 - 10:44 am

Yes, no, maybe: FDA panel delivers mixed verdict on AstraZeneca's asthma rescue medication

Fierce Biotech

Wed, 11/9/22 - 10:43 am

Pages